Broadfin Capital, LLC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 105 filers reported holding ARATANA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$37,452,000
+43.3%
7,258,1350.0%8.15%
+51.0%
Q1 2019$26,129,000
+4.4%
7,258,135
+77.8%
5.40%
+63.9%
Q4 2018$25,030,000
+5.0%
4,083,1350.0%3.29%
-6.2%
Q3 2018$23,846,000
+30.7%
4,083,135
-4.9%
3.51%
+22.1%
Q2 2018$18,251,000
-3.6%
4,294,4260.0%2.87%
-2.6%
Q1 2018$18,938,000
-16.2%
4,294,4260.0%2.95%
-20.1%
Q4 2017$22,589,000
-28.9%
4,294,426
-17.2%
3.69%
-21.5%
Q3 2017$31,784,000
-15.2%
5,184,9420.0%4.70%
+3.2%
Q2 2017$37,487,000
+91.4%
5,184,942
+40.3%
4.55%
+92.0%
Q1 2017$19,586,000
-26.2%
3,695,4420.0%2.37%
-19.5%
Q4 2016$26,533,000
-8.1%
3,695,442
+19.7%
2.95%
+13.8%
Q3 2016$28,885,000
+33.3%
3,085,979
-10.0%
2.59%
+22.9%
Q2 2016$21,670,000
+14.5%
3,428,8650.0%2.11%
+15.3%
Q1 2016$18,927,000
-1.1%
3,428,8650.0%1.83%
+55.3%
Q4 2015$19,133,000
+72.7%
3,428,865
+161.8%
1.18%
+90.8%
Q3 2015$11,081,000
-35.3%
1,309,865
+15.7%
0.62%
-32.9%
Q2 2015$17,114,000
-5.6%
1,131,8650.0%0.92%
-34.8%
Q1 2015$18,121,000
-59.6%
1,131,865
-55.1%
1.41%
-27.7%
Q4 2014$44,888,000
+210.0%
2,518,942
+74.6%
1.95%
+28.6%
Q3 2014$14,482,000
-43.3%
1,442,435
-11.8%
1.52%
+20.9%
Q2 2014$25,520,000
+106.0%
1,634,870
+144.9%
1.26%
+4.7%
Q1 2014$12,388,000667,4351.20%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders